Navigation Links
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Date:8/19/2007

d a two-stage min-max design in which if there were at least nine responses in the first 42 patients, the trial was to continue to the second stage. On January 25, 2007, the Company announced that there had been at least nine remissions in the first stage and that the trial would therefore continue. Eighty-five patients were enrolled in order to ensure that at least 77 would be eligible for the trial and included in the full analysis set. At least 22 responses in 77 patients are required to confirm the 35% target response rate with 95% confidence. If the full analysis set includes all 85 patients, then at least 24 responses are required for confirmation of the target response rate.

Dr. Dan DeAngelo, Assistant Professor at Harvard Medical School and the Dana Farber Cancer Institute and an investigator on the trial commented, "The treatment of elderly patients with poor-risk AML represents a significant unmet medical need in clinical oncology, and it is important that we find new effective treatment options. Agents such as Cloretazine(R) (VNP40101M) have the potential to address this need."

Dr. Gary Schiller, Professor of Medicine at the UCLA Geffen School of Medicine and an investigator on the trial added, "This was a very important study for older AML patients treated here at UCLA. As a single agent therapy administered over 30 to 60 minutes, Cloretazine(R) (VNP40101M) is clearly an active agent with the potential to play an important role in the treatment of this difficult population."

On August 8, 2007, the Company announced that certain sites on the trial would remain open and continue to accrue patients to an ECG sub-study. Recent FDA/ICH guidance recommends that an electrocardiographic evaluation (QT/QTc) study be included in the clinical development of all new drugs. Normally these studies are conducted in healthy subjects so that disease factors/co- morbidities do not confound the results. As Cloretazine(R) (VNP40101M) is a cytotoxic agent w
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research and Markets( http://www.researchandmarkets.com/research/c8jldk/global_healthcare ... Healthcare BPO Market 2015-2019" report to their offering. ... F&A BPO, HR BPO and CRM BPO to grow ... BPO is a segment of outsourcing, which ... to a third-party vendor that has the expertise in ...
(Date:5/27/2015)... , May 27, 2015  MT Services ... operates lawsuitsettlementnews.com, reports today the most up-to-date news ... Stryker , DePuy, Wright, and ... certain litigations are still dragging on and waiting ... Corporation: Stryker Corporation has agreed to pay $1.43 ...
(Date:5/27/2015)... Jeder Fernreisende weiß, ... enorm. Es ist schwierig konzentriert zu bleiben, bei ... Zeitpunkt in einem Hotelzimmer auf, ohne sich  erholt ... zurückgekehrt, fühlt man sich  oft nicht in ... etwas zu unternehmen oder bei der Arbeit ...
Breaking Medicine Technology:Global Healthcare BPO Market 2015-2019 - Emergence of Cloud-based BPO in Healthcare with Accenture, Cognizant, Genpact, IBM, TCS, Wipro & Xerox Dominating 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 2Major Hip Settlements Reported by Lawsuitsettlementnews.com 3Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 2Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 3Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 4
(Date:5/27/2015)... May 27, 2015 For a limited time, ... is now offering discounts on facial fillers. Skin loses more ... age of 18. This lost collagen can lead to thinning ... and expression lines. Facial fillers are an excellent way to ... to facial fillers to create a softer and more youthful ...
(Date:5/27/2015)... Holly CaSaroll, founder of FACE, the award-winning beauty clinic, ... The skin is the body’s largest organ and is exposed ... million cases of skin cancer are diagnosed in the United ... ultraviolet rays (UVR). , There are several things people ... the sun between the hours of 10 AM and 4 ...
(Date:5/27/2015)... Congratulations to all 50 winners of ... Award. From June 1, 2014 to June 1, 2015, ... alcohol addiction treatment centers around the country for their ... random at addiction treatment conferences throughout the past year. ... said, “Sky Toxicology would like to thank everyone for ...
(Date:5/27/2015)... With the FCPX LUT Cross Processed Plugin ... easily add filmic color grades to their footage. This pack ... LUT Cross Processed Plugin can instantly make give any footage ... in between. , FCPX LUT Cross Processed Plugin files are ... softwares. With the FCPX LUT Cross Processed Loader from Pixel ...
(Date:5/27/2015)... 27, 2015 National Healthcare ... award winning web development and interactive marketing ... the launch of its newly redesigned, custom ... National Healthcare Providers, is a physician owned ... the areas of Radiology, Anesthesiology, Emergency and ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 2Health News:Sky Toxicology Reaches Their $500,000 Goal in Drug and Alcohol Addiction Treatment Patient Scholarship Awards 3Health News:Developers at Pixel Film Studios Release FCPX LUT Cross Processed Plugin for Final Cut Pro X 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3
... Fla., Oct. 12 After helping thousands of patients get their ... Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute ... facilities -- in Beverly ... Fla., in October -- which aim to meet ...
... shot for kicking nicotine addiction , MONDAY, Oct. 12 (HealthDay ... a $10 million grant to a Maryland company to help ... anti-nicotine vaccine. , Nabi Biopharmaceuticals of Rockville will launch ... The study, which could be the last step of research ...
... ... ... -- Gary C. Baker was recently hired to energize the role of Chief Financial ... quality improvement and care management organization. Mr. Baker brings his extensive experience in re-engineering ...
... WEST PALM BEACH, Fla., Oct. 12 The inaugural ... specialties was called an unqualified success by those that ... attended, the meeting was a great learning opportunity and ... Bootcamp LLC and its corporate partners. Attendees came ...
... LAS VEGAS, Oct. 12 Noninvasive Medical Technologies, ... remote patient monitoring solutions, is pleased to commit its support ... highly motivated men in two man teams are currently relay ... ruck sacks and a memorial plaque with Staff Sgt. Tim ...
... cells are being used to help develop a heart muscle ... have achieved a first step toward growing a living "heart ... embryonic stem cells, Duke University bioengineers performed a series of ... into heart muscle. , The researchers used a special mold ...
Cached Medicine News:Health News:Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 2Health News:Stop-Smoking Vaccine in the Works 2Health News:Gary C. Baker Named KePRO Chief Financial Officer 2Health News:Gary C. Baker Named KePRO Chief Financial Officer 3Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 2Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 3Health News:Lab Study Makes Strides in Mending Hearts 2
Disposable Aluminum Satin Finish E/T Stylette, Adult 16, 25/box....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Surgical Stainless Steel Adult 16.5....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Medicine Products: